Search research articles
Contact Us
Filters
Showing results (141-150 of 169) with videos related to
Page
of 17
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2004
Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?
P G Ambrose, D Bast, G V Doern, et al.
Journal of Clinical Microbiology
|
August 1, 1996
Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin
S A Marshall, R N Jones, A Wanger, et al.
Antimicrobial Agents and Chemotherapy
|
September 3, 1999
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America
D J Diekema, M A Pfaller, S A Messer, et al.
International Journal of Antimicrobial Agents
|
December 14, 1999
A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions
S S Richter, A B Brueggemann, H K Huynh, et al.
Diagnostic Microbiology and Infectious Disease
|
February 6, 1999
Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group
H S Sader, R N Jones, A C Gales, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 6, 2001
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998
D J Diekema, M A Pfaller, J Turnidge, et al.
Antimicrobial Agents and Chemotherapy
|
January 20, 2000
Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998
S S Richter, P L Winokur, A B Brueggemann, et al.
Journal of Clinical Microbiology
|
June 29, 2002
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm
S S Richter, S E Beekmann, J L Croco, et al.
Journal of Clinical Microbiology
|
March 30, 2002
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study
D J Diekema, S A Messer, A B Brueggemann, et al.
Journal of Clinical Microbiology
|
May 6, 2005
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)
M A Pfaller, S A Messer, L Boyken, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 169) with videos related to
Sort By:
Page
of 17
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2004
Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?
P G Ambrose, D Bast, G V Doern, et al.
Journal of Clinical Microbiology
|
August 1, 1996
Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin
S A Marshall, R N Jones, A Wanger, et al.
Antimicrobial Agents and Chemotherapy
|
September 3, 1999
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America
D J Diekema, M A Pfaller, S A Messer, et al.
International Journal of Antimicrobial Agents
|
December 14, 1999
A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions
S S Richter, A B Brueggemann, H K Huynh, et al.
Diagnostic Microbiology and Infectious Disease
|
February 6, 1999
Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group
H S Sader, R N Jones, A C Gales, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 6, 2001
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998
D J Diekema, M A Pfaller, J Turnidge, et al.
Antimicrobial Agents and Chemotherapy
|
January 20, 2000
Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998
S S Richter, P L Winokur, A B Brueggemann, et al.
Journal of Clinical Microbiology
|
June 29, 2002
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm
S S Richter, S E Beekmann, J L Croco, et al.
Journal of Clinical Microbiology
|
March 30, 2002
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study
D J Diekema, S A Messer, A B Brueggemann, et al.
Journal of Clinical Microbiology
|
May 6, 2005
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)
M A Pfaller, S A Messer, L Boyken, et al.
Page
of 17